LifeSciences BC Announces Our Next Breakfast Speaking Series - Keening Your Edge With Dr. Mathai Mammen of the Bay Area's Theravance And local community members Dr. Michael Hayden of the BC Clinical Genomics Network and Bruce Schmidt of Genome BC Time:  7:30am – 9:00am Place:  Sutton Place Hotel Registration: click here LifeSciences BC is pleased to welcome Bruce Schmidt, Director of Corporate Development at Genome BC, and Dr. Michael Hayden, Principle Investigator, British Columbia Clinical Genomics Network, who will represent our local community at this Breakfast Speaking Series.  Research is the foundation of our industry, and it's important that we understand and appreciate the role of organizations like these that are formed specifically to support that research. LifeSciences BC is also pleased to welcome Theravance’s Dr. Mathai Mammen as our featured speaker for the next Breakfast Speaking Series.  As a Harvard- and MIT-educated scientific founder and head of research at Theravance, Mammen will share his story of building this billion-dollar Bay Area company, right from getting it off the ground to verging on market approval. Mammen will share how he’s honed Theravance’s unique edge of multivalent drug design, nurturing it every day and leveraging it to successfully raise money; develop strategic partnerships with the likes of GSK, Astellas and AstraZeneca; create a differentiating culture where he can hire the best in the industry; build a robust pipeline of seven products in the clinic, and ultimately deal with the FDA for the pending approval of their lead product. These are the challenges along the way for every biotech company, and Mammen will share how Theravance has survived and thrived in this difficult industry. Bio Mathai Mammen, M.D., Ph.D. Mathai Mammen, M.D., Ph.D., co-founded Theravance in 1996. He was promoted to Senior Vice President, Research, in January 2008. He has served in various positions in both the Medicinal Chemistry Department and the Molecular and Cellular Biology Department, most recently as Vice President, Molecular and Cellular Biology, responsible for all molecular pharmacology, molecular biology, cell biology, microbiology and enzymology activities in support of projects in both Research and Development. Dr. Mammen obtained his M.D. from Harvard Medical School/Massachusetts Institute of Technology, and his Ph.D. in Physical Organic Chemistry from Harvard University's Department of Chemistry. Dr. Mammen obtained his Bachelor's Degree in Chemistry from Dalhousie University in Halifax, Nova Scotia. LifeSciences BC's Breakfast Speaking Series is generously sponsored by:

send this to a friend unsubscrive © LifeSciences British Columbia. All rights reserved.

Suite 900 - 1188 West Georgia St. Vancouver, BC V6E 4A2